# Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer

> **NCT02271464** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliero, Universitaria Pisana** · enrollment: 232 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Maintenance:BEVACIZUMAB
- **DRUG:** Maintenance:BEVACIZUMAB+CAPECITABINE+CYCLOPHOSPHAMIDE

## Key facts

- **NCT ID:** NCT02271464
- **Lead sponsor:** Azienda Ospedaliero, Universitaria Pisana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-09
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271464, "Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02271464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*